カテゴリー： 世界, 医療/バイオ, Market Monitor Global

世界の新型コロナ感染症抗ウイルス経口薬市場予測2023-2029：錠剤、カプセル

【英語タイトル】Oral COVID-19 Antiviral Medicine Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが出版した調査資料（MMG23FB2497）・商品コード：MMG23FB2497
・発行会社（調査会社）：Market Monitor Global
・発行日：2023年2月
・ページ数：72
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の新型コロナ感染症抗ウイルス経口薬市場規模と予測を収録しています。・世界の新型コロナ感染症抗ウイルス経口薬市場：売上、2018年-2023年、2024年-2029年
・世界の新型コロナ感染症抗ウイルス経口薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の新型コロナ感染症抗ウイルス経口薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「錠剤」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

新型コロナ感染症抗ウイルス経口薬のグローバル主要企業は、Merck and Ridgebackなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、新型コロナ感染症抗ウイルス経口薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の新型コロナ感染症抗ウイルス経口薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の新型コロナ感染症抗ウイルス経口薬市場：タイプ別市場シェア、2022年
・錠剤、カプセル

世界の新型コロナ感染症抗ウイルス経口薬市場：用途別、2018年-2023年、2024年-2029年
世界の新型コロナ感染症抗ウイルス経口薬市場：用途別市場シェア、2022年
・病院、診療所

世界の新型コロナ感染症抗ウイルス経口薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の新型コロナ感染症抗ウイルス経口薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における新型コロナ感染症抗ウイルス経口薬のグローバル売上、2018年-2023年
・主要企業における新型コロナ感染症抗ウイルス経口薬のグローバル売上シェア、2022年
・主要企業における新型コロナ感染症抗ウイルス経口薬のグローバル販売量、2018年-2023年
・主要企業における新型コロナ感染症抗ウイルス経口薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Merck and Ridgeback

*************************************************************

・調査・分析レポートの概要
新型コロナ感染症抗ウイルス経口薬市場の定義
市場セグメント
世界の新型コロナ感染症抗ウイルス経口薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の新型コロナ感染症抗ウイルス経口薬市場規模
世界の新型コロナ感染症抗ウイルス経口薬市場規模：2022年 VS 2029年
世界の新型コロナ感染症抗ウイルス経口薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの新型コロナ感染症抗ウイルス経口薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の新型コロナ感染症抗ウイルス経口薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：錠剤、カプセル
新型コロナ感染症抗ウイルス経口薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、診療所
新型コロナ感染症抗ウイルス経口薬の用途別グローバル売上・予測

・地域別市場分析
地域別新型コロナ感染症抗ウイルス経口薬市場規模 2022年と2029年
地域別新型コロナ感染症抗ウイルス経口薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Merck and Ridgeback
…

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Oral COVID-19 Antiviral Medicine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Oral COVID-19 Antiviral Medicine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Oral COVID-19 Antiviral Medicine Overall Market Size
2.1 Global Oral COVID-19 Antiviral Medicine Market Size: 2022 VS 2029
2.2 Global Oral COVID-19 Antiviral Medicine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Oral COVID-19 Antiviral Medicine Sales: 2018-2029
3 Company Landscape
3.1 Top Oral COVID-19 Antiviral Medicine Players in Global Market
3.2 Top Global Oral COVID-19 Antiviral Medicine Companies Ranked by Revenue
3.3 Global Oral COVID-19 Antiviral Medicine Revenue by Companies
3.4 Global Oral COVID-19 Antiviral Medicine Sales by Companies
3.5 Global Oral COVID-19 Antiviral Medicine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Oral COVID-19 Antiviral Medicine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Oral COVID-19 Antiviral Medicine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Oral COVID-19 Antiviral Medicine Players in Global Market
3.8.1 List of Global Tier 1 Oral COVID-19 Antiviral Medicine Companies
3.8.2 List of Global Tier 2 and Tier 3 Oral COVID-19 Antiviral Medicine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Oral COVID-19 Antiviral Medicine Market Size Markets, 2022 & 2029
4.1.2 Tablet
4.1.3 Capsule
4.2 By Type – Global Oral COVID-19 Antiviral Medicine Revenue & Forecasts
4.2.1 By Type – Global Oral COVID-19 Antiviral Medicine Revenue, 2018-2023
4.2.2 By Type – Global Oral COVID-19 Antiviral Medicine Revenue, 2024-2029
4.2.3 By Type – Global Oral COVID-19 Antiviral Medicine Revenue Market Share, 2018-2029
4.3 By Type – Global Oral COVID-19 Antiviral Medicine Sales & Forecasts
4.3.1 By Type – Global Oral COVID-19 Antiviral Medicine Sales, 2018-2023
4.3.2 By Type – Global Oral COVID-19 Antiviral Medicine Sales, 2024-2029
4.3.3 By Type – Global Oral COVID-19 Antiviral Medicine Sales Market Share, 2018-2029
4.4 By Type – Global Oral COVID-19 Antiviral Medicine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Oral COVID-19 Antiviral Medicine Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.2 By Application – Global Oral COVID-19 Antiviral Medicine Revenue & Forecasts
5.2.1 By Application – Global Oral COVID-19 Antiviral Medicine Revenue, 2018-2023
5.2.2 By Application – Global Oral COVID-19 Antiviral Medicine Revenue, 2024-2029
5.2.3 By Application – Global Oral COVID-19 Antiviral Medicine Revenue Market Share, 2018-2029
5.3 By Application – Global Oral COVID-19 Antiviral Medicine Sales & Forecasts
5.3.1 By Application – Global Oral COVID-19 Antiviral Medicine Sales, 2018-2023
5.3.2 By Application – Global Oral COVID-19 Antiviral Medicine Sales, 2024-2029
5.3.3 By Application – Global Oral COVID-19 Antiviral Medicine Sales Market Share, 2018-2029
5.4 By Application – Global Oral COVID-19 Antiviral Medicine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Oral COVID-19 Antiviral Medicine Market Size, 2022 & 2029
6.2 By Region – Global Oral COVID-19 Antiviral Medicine Revenue & Forecasts
6.2.1 By Region – Global Oral COVID-19 Antiviral Medicine Revenue, 2018-2023
6.2.2 By Region – Global Oral COVID-19 Antiviral Medicine Revenue, 2024-2029
6.2.3 By Region – Global Oral COVID-19 Antiviral Medicine Revenue Market Share, 2018-2029
6.3 By Region – Global Oral COVID-19 Antiviral Medicine Sales & Forecasts
6.3.1 By Region – Global Oral COVID-19 Antiviral Medicine Sales, 2018-2023
6.3.2 By Region – Global Oral COVID-19 Antiviral Medicine Sales, 2024-2029
6.3.3 By Region – Global Oral COVID-19 Antiviral Medicine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Oral COVID-19 Antiviral Medicine Revenue, 2018-2029
6.4.2 By Country – North America Oral COVID-19 Antiviral Medicine Sales, 2018-2029
6.4.3 US Oral COVID-19 Antiviral Medicine Market Size, 2018-2029
6.4.4 Canada Oral COVID-19 Antiviral Medicine Market Size, 2018-2029
6.4.5 Mexico Oral COVID-19 Antiviral Medicine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Oral COVID-19 Antiviral Medicine Revenue, 2018-2029
6.5.2 By Country – Europe Oral COVID-19 Antiviral Medicine Sales, 2018-2029
6.5.3 Germany Oral COVID-19 Antiviral Medicine Market Size, 2018-2029
6.5.4 France Oral COVID-19 Antiviral Medicine Market Size, 2018-2029
6.5.5 U.K. Oral COVID-19 Antiviral Medicine Market Size, 2018-2029
6.5.6 Italy Oral COVID-19 Antiviral Medicine Market Size, 2018-2029
6.5.7 Russia Oral COVID-19 Antiviral Medicine Market Size, 2018-2029
6.5.8 Nordic Countries Oral COVID-19 Antiviral Medicine Market Size, 2018-2029
6.5.9 Benelux Oral COVID-19 Antiviral Medicine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Oral COVID-19 Antiviral Medicine Revenue, 2018-2029
6.6.2 By Region – Asia Oral COVID-19 Antiviral Medicine Sales, 2018-2029
6.6.3 China Oral COVID-19 Antiviral Medicine Market Size, 2018-2029
6.6.4 Japan Oral COVID-19 Antiviral Medicine Market Size, 2018-2029
6.6.5 South Korea Oral COVID-19 Antiviral Medicine Market Size, 2018-2029
6.6.6 Southeast Asia Oral COVID-19 Antiviral Medicine Market Size, 2018-2029
6.6.7 India Oral COVID-19 Antiviral Medicine Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Oral COVID-19 Antiviral Medicine Revenue, 2018-2029
6.7.2 By Country – South America Oral COVID-19 Antiviral Medicine Sales, 2018-2029
6.7.3 Brazil Oral COVID-19 Antiviral Medicine Market Size, 2018-2029
6.7.4 Argentina Oral COVID-19 Antiviral Medicine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Oral COVID-19 Antiviral Medicine Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Oral COVID-19 Antiviral Medicine Sales, 2018-2029
6.8.3 Turkey Oral COVID-19 Antiviral Medicine Market Size, 2018-2029
6.8.4 Israel Oral COVID-19 Antiviral Medicine Market Size, 2018-2029
6.8.5 Saudi Arabia Oral COVID-19 Antiviral Medicine Market Size, 2018-2029
6.8.6 UAE Oral COVID-19 Antiviral Medicine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Merck and Ridgeback
7.1.1 Merck and Ridgeback Company Summary
7.1.2 Merck and Ridgeback Business Overview
7.1.3 Merck and Ridgeback Oral COVID-19 Antiviral Medicine Major Product Offerings
7.1.4 Merck and Ridgeback Oral COVID-19 Antiviral Medicine Sales and Revenue in Global (2018-2023)
7.1.5 Merck and Ridgeback Key News & Latest Developments
8 Global Oral COVID-19 Antiviral Medicine Production Capacity, Analysis
8.1 Global Oral COVID-19 Antiviral Medicine Production Capacity, 2018-2029
8.2 Oral COVID-19 Antiviral Medicine Production Capacity of Key Manufacturers in Global Market
8.3 Global Oral COVID-19 Antiviral Medicine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Oral COVID-19 Antiviral Medicine Supply Chain Analysis
10.1 Oral COVID-19 Antiviral Medicine Industry Value Chain
10.2 Oral COVID-19 Antiviral Medicine Upstream Market
10.3 Oral COVID-19 Antiviral Medicine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Oral COVID-19 Antiviral Medicine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Oral COVID-19 Antiviral Medicine in Global Market
Table 2. Top Oral COVID-19 Antiviral Medicine Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Oral COVID-19 Antiviral Medicine Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Oral COVID-19 Antiviral Medicine Revenue Share by Companies, 2018-2023
Table 5. Global Oral COVID-19 Antiviral Medicine Sales by Companies, (K Units), 2018-2023
Table 6. Global Oral COVID-19 Antiviral Medicine Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Oral COVID-19 Antiviral Medicine Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Oral COVID-19 Antiviral Medicine Product Type
Table 9. List of Global Tier 1 Oral COVID-19 Antiviral Medicine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Oral COVID-19 Antiviral Medicine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Oral COVID-19 Antiviral Medicine Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Oral COVID-19 Antiviral Medicine Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Oral COVID-19 Antiviral Medicine Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Oral COVID-19 Antiviral Medicine Sales (K Units), 2018-2023
Table 15. By Type - Global Oral COVID-19 Antiviral Medicine Sales (K Units), 2024-2029
Table 16. By Application – Global Oral COVID-19 Antiviral Medicine Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Oral COVID-19 Antiviral Medicine Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Oral COVID-19 Antiviral Medicine Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Oral COVID-19 Antiviral Medicine Sales (K Units), 2018-2023
Table 20. By Application - Global Oral COVID-19 Antiviral Medicine Sales (K Units), 2024-2029
Table 21. By Region – Global Oral COVID-19 Antiviral Medicine Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Oral COVID-19 Antiviral Medicine Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Oral COVID-19 Antiviral Medicine Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Oral COVID-19 Antiviral Medicine Sales (K Units), 2018-2023
Table 25. By Region - Global Oral COVID-19 Antiviral Medicine Sales (K Units), 2024-2029
Table 26. By Country - North America Oral COVID-19 Antiviral Medicine Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Oral COVID-19 Antiviral Medicine Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Oral COVID-19 Antiviral Medicine Sales, (K Units), 2018-2023
Table 29. By Country - North America Oral COVID-19 Antiviral Medicine Sales, (K Units), 2024-2029
Table 30. By Country - Europe Oral COVID-19 Antiviral Medicine Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Oral COVID-19 Antiviral Medicine Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Oral COVID-19 Antiviral Medicine Sales, (K Units), 2018-2023
Table 33. By Country - Europe Oral COVID-19 Antiviral Medicine Sales, (K Units), 2024-2029
Table 34. By Region - Asia Oral COVID-19 Antiviral Medicine Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Oral COVID-19 Antiviral Medicine Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Oral COVID-19 Antiviral Medicine Sales, (K Units), 2018-2023
Table 37. By Region - Asia Oral COVID-19 Antiviral Medicine Sales, (K Units), 2024-2029
Table 38. By Country - South America Oral COVID-19 Antiviral Medicine Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Oral COVID-19 Antiviral Medicine Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Oral COVID-19 Antiviral Medicine Sales, (K Units), 2018-2023
Table 41. By Country - South America Oral COVID-19 Antiviral Medicine Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Oral COVID-19 Antiviral Medicine Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Oral COVID-19 Antiviral Medicine Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Oral COVID-19 Antiviral Medicine Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Oral COVID-19 Antiviral Medicine Sales, (K Units), 2024-2029
Table 46. Merck and Ridgeback Company Summary
Table 47. Merck and Ridgeback Oral COVID-19 Antiviral Medicine Product Offerings
Table 48. Merck and Ridgeback Oral COVID-19 Antiviral Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Merck and Ridgeback Key News & Latest Developments
Table 50. Oral COVID-19 Antiviral Medicine Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 51. Global Oral COVID-19 Antiviral Medicine Capacity Market Share of Key Manufacturers, 2021-2023
Table 52. Global Oral COVID-19 Antiviral Medicine Production by Region, 2018-2023 (K Units)
Table 53. Global Oral COVID-19 Antiviral Medicine Production by Region, 2024-2029 (K Units)
Table 54. Oral COVID-19 Antiviral Medicine Market Opportunities & Trends in Global Market
Table 55. Oral COVID-19 Antiviral Medicine Market Drivers in Global Market
Table 56. Oral COVID-19 Antiviral Medicine Market Restraints in Global Market
Table 57. Oral COVID-19 Antiviral Medicine Raw Materials
Table 58. Oral COVID-19 Antiviral Medicine Raw Materials Suppliers in Global Market
Table 59. Typical Oral COVID-19 Antiviral Medicine Downstream
Table 60. Oral COVID-19 Antiviral Medicine Downstream Clients in Global Market
Table 61. Oral COVID-19 Antiviral Medicine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Oral COVID-19 Antiviral Medicine Segment by Type in 2022
Figure 2. Oral COVID-19 Antiviral Medicine Segment by Application in 2022
Figure 3. Global Oral COVID-19 Antiviral Medicine Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Oral COVID-19 Antiviral Medicine Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Oral COVID-19 Antiviral Medicine Revenue, 2018-2029 (US$, Mn)
Figure 7. Oral COVID-19 Antiviral Medicine Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Oral COVID-19 Antiviral Medicine Revenue in 2022
Figure 9. By Type - Global Oral COVID-19 Antiviral Medicine Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Oral COVID-19 Antiviral Medicine Revenue Market Share, 2018-2029
Figure 11. By Type - Global Oral COVID-19 Antiviral Medicine Sales Market Share, 2018-2029
Figure 12. By Type - Global Oral COVID-19 Antiviral Medicine Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Oral COVID-19 Antiviral Medicine Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Oral COVID-19 Antiviral Medicine Revenue Market Share, 2018-2029
Figure 15. By Application - Global Oral COVID-19 Antiviral Medicine Sales Market Share, 2018-2029
Figure 16. By Application - Global Oral COVID-19 Antiviral Medicine Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Oral COVID-19 Antiviral Medicine Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Oral COVID-19 Antiviral Medicine Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Oral COVID-19 Antiviral Medicine Revenue Market Share, 2018-2029
Figure 20. By Region - Global Oral COVID-19 Antiviral Medicine Sales Market Share, 2018-2029
Figure 21. By Country - North America Oral COVID-19 Antiviral Medicine Revenue Market Share, 2018-2029
Figure 22. By Country - North America Oral COVID-19 Antiviral Medicine Sales Market Share, 2018-2029
Figure 23. US Oral COVID-19 Antiviral Medicine Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Oral COVID-19 Antiviral Medicine Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Oral COVID-19 Antiviral Medicine Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Oral COVID-19 Antiviral Medicine Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Oral COVID-19 Antiviral Medicine Sales Market Share, 2018-2029
Figure 28. Germany Oral COVID-19 Antiviral Medicine Revenue, (US$, Mn), 2018-2029
Figure 29. France Oral COVID-19 Antiviral Medicine Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Oral COVID-19 Antiviral Medicine Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Oral COVID-19 Antiviral Medicine Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Oral COVID-19 Antiviral Medicine Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Oral COVID-19 Antiviral Medicine Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Oral COVID-19 Antiviral Medicine Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Oral COVID-19 Antiviral Medicine Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Oral COVID-19 Antiviral Medicine Sales Market Share, 2018-2029
Figure 37. China Oral COVID-19 Antiviral Medicine Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Oral COVID-19 Antiviral Medicine Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Oral COVID-19 Antiviral Medicine Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Oral COVID-19 Antiviral Medicine Revenue, (US$, Mn), 2018-2029
Figure 41. India Oral COVID-19 Antiviral Medicine Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Oral COVID-19 Antiviral Medicine Revenue Market Share, 2018-2029
Figure 43. By Country - South America Oral COVID-19 Antiviral Medicine Sales Market Share, 2018-2029
Figure 44. Brazil Oral COVID-19 Antiviral Medicine Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Oral COVID-19 Antiviral Medicine Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Oral COVID-19 Antiviral Medicine Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Oral COVID-19 Antiviral Medicine Sales Market Share, 2018-2029
Figure 48. Turkey Oral COVID-19 Antiviral Medicine Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Oral COVID-19 Antiviral Medicine Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Oral COVID-19 Antiviral Medicine Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Oral COVID-19 Antiviral Medicine Revenue, (US$, Mn), 2018-2029
Figure 52. Global Oral COVID-19 Antiviral Medicine Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Oral COVID-19 Antiviral Medicine by Region, 2022 VS 2029
Figure 54. Oral COVID-19 Antiviral Medicine Industry Value Chain
Figure 55. Marketing Channels


★調査レポート[世界の新型コロナ感染症抗ウイルス経口薬市場予測2023-2029：錠剤、カプセル] (コード：MMG23FB2497)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の新型コロナ感染症抗ウイルス経口薬市場予測2023-2029：錠剤、カプセル]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の経口新型コロナウイルス感染症治療薬市場予測2023-2029：錠剤、カプセル
  • 世界の経口製剤用薬品添加剤市場予測2023-2029：錠剤、カプセル
  • 世界のアレルギー&副鼻腔炎薬市場予測2023-2029：カプセル、スプレー、液体、錠剤、その他
  • 世界のアカルボース医薬品市場予測2023-2029：錠剤、カプセル
  • 世界のオセルタミビル市場予測2023-2029：カプセル、内服液
  • 世界のガチフロキサシン市場予測2023-2029：錠剤、水溶液、カプセル、その他
  • 世界のミトタン市場予測2023-2029：錠剤、カプセル
  • 世界の医療用亜セレン酸ナトリウム市場予測2023-2029：カプセル、錠剤、その他
  • 世界のドフェチリド市場予測2023-2029：カプセル、その他
  • 世界のナロキセゴール市場予測2023-2029：錠剤、カプセル

    • ◆H&Iグローバルリサーチのお客様（例）◆